Jump to content
Wikipedia The Free Encyclopedia

Bufetolol

From Wikipedia, the free encyclopedia
Bufetolol
Names
IUPAC name
1-(tert-Butylamino)-3-[2-(oxolan-2-ylmethoxy)phenoxy]propan-2-ol
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
KEGG
UNII
  • InChI=1S/C18H29NO4/c1-18(2,3)19-11-14(20)12-22-16-8-4-5-9-17(16)23-13-15-7-6-10-21-15/h4-5,8-9,14-15,19-20H,6-7,10-13H2,1-3H3
    Key:AKLNLVOZXMQGSI-UHFFFAOYSA-N
  • InChI=1/C18H29NO4/c1-18(2,3)19-11-14(20)12-22-16-8-4-5-9-17(16)23-13-15-7-6-10-21-15/h4-5,8-9,14-15,19-20H,6-7,10-13H2,1-3H3
    Key:AKLNLVOZXMQGSI-UHFFFAOYAN
  • CC(C)(C)NCC(COC1=CC=CC=C1OCC2CCCO2)O
Properties
C18H29NO4
Molar mass 323.433g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25°C [77°F], 100kPa).
Chemical compound

Bufetolol is a beta-adrenoceptor antagonist.[1]

References

[edit ]
  1. Sada, H; Harada, S; Ban, T (1983). "Effects of beta-adrenoceptor blocking agents of N-tertiary butyl derivatives on maximum upstroke velocity of action potential in guinea-pig papillary muscles". Naunyn-Schmiedeberg's Archives of Pharmacology. 324 (1): 50–7. doi:10.1007/bf00647838. PMID 6138715.
Stub icon

This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by adding missing information.

AltStyle によって変換されたページ (->オリジナル) /